We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Fabrinet
FN
$16.9B
| $590K | 0.09% |
+18,243
| New | +$491K |
|
|
UNT
402
DELISTED
UNIT Corporation
UNT
| $590K | 0.09% |
66,949
-113,116
| -63% | -$968K |
|
403
Saic
SAIC
$5.01B
| $588K | 0.08% |
+11,021
| New | +$490K |
|
|
CUTR
404
DELISTED
Cutera, Inc.
CUTR
| $586K | 0.08% |
+52,049
| New | +$591K |
|
405
Xencor
XNCR
$1.47B
| $584K | 0.08% |
43,500
-377,477
| -90% | -$4.47M |
|
|
MRIN
406
DELISTED
Marin Software
MRIN
| $580K | 0.08% |
+4,571
| New | +$598K |
|
|
FMBI
407
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $580K | 0.08% |
32,177
-17,484
| -35% | -$301K |
|
408
CONMED
CNMD
$1.31B
| $578K | 0.08% |
13,780
-58,818
| -81% | -$2.31M |
|
409
Malibu Boats
MBUU
$557M
| $576K | 0.08% |
+35,118
| New | +$513K |
|
|
CHFN
410
DELISTED
Charter Financial Corp
CHFN
| $570K | 0.08% |
+42,204
| New | +$563K |
|
411
Marcus Corp
MCS
$752M
| $568K | 0.08% |
29,994
+16,831
| +128% | +$315K |
|
|
NPTN
412
DELISTED
NEOPHOTONICS CORP
NPTN
| $568K | 0.08% |
+40,455
| New | +$419K |
|
413
Seacoast Banking Corp of Florida
SBCF
$3.23B
| $563K | 0.08% |
+35,637
| New | +$527K |
|
414
Kemper
KMPR
$1.73B
| $557K | 0.08% |
18,838
-21,903
| -54% | -$657K |
|
|
SGMO
415
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $550K | 0.08% |
+90,971
| New | +$546K |
|
416
Astec Industries
ASTE
$1.29B
| $547K | 0.08% |
+11,725
| New | +$469K |
|
|
NEWP
417
DELISTED
NEWPORT CORP
NEWP
| $546K | 0.08% |
23,718
+399
| +2% | +$7.29K |
|
418
BlackRock Resources & Commodities Strategy Trust
BCX
$894M
| $541K | 0.08% |
+75,007
| New | +$501K |
|
419
Marten Transport
MRTN
$1.26B
| $539K | 0.08% |
71,953
+15,975
| +29% | +$110K |
|
|
DOOR
420
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $536K | 0.08% |
+8,181
| New | +$462K |
|
|
SFLY
421
DELISTED
Shutterfly, Inc.
SFLY
| $536K | 0.08% |
+11,566
| New | +$493K |
|
|
PFSW
422
DELISTED
PFSweb, Inc.
PFSW
| $536K | 0.08% |
40,820
+28,322
| +227% | +$351K |
|
|
SUM
423
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $535K | 0.08% |
+28,711
| New | +$470K |
|
|
TBHC
424
DELISTED
The Brand House Collective
TBHC
| $532K | 0.08% |
+30,370
| New | +$424K |
|
425
Liquidity Services
LQDT
$1.21B
| $532K | 0.08% |
102,647
-278,770
| -73% | -$1.49M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.